top of page
Our
Analytics
Insper Asset is divided into three areas: equity research, private equity and fixed income. All members are responsible for developing analyzes within each respective nucleus. Check out some of our best reviews below.
Equity Research
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Equity Research
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
Catalyst Pharmaceuticals - 2023.2
Developed by members Bruna Fragali and Edaurdo Cardillo, together with head Pedro Magalhães.
bottom of page